Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial.

Cancers (Basel) · 2022 · PMC9367267 · PMID 35954471

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significancep -value = 0.12not close (p > 0.1)

However, in the non-luminal A subgroup, differences did not reach statistical significance (multivariate HR = 0.94, 95% CI = 0.88–1.02; p -value = 0.12).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.